Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
57 participants
OBSERVATIONAL
2013-03-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurohormonal Parameters in Hypertrophic Cardiomyopathies
NCT01729702
Biological and Electrocardiographic Biomarkers for Risk Stratification in Hypertension.
NCT03068364
Multi Point Pacing vs. Conventional STUDY PROTOCOL
NCT04334018
Echocardiographic Analysis by Artificial Intelligence in Hypertension
NCT06680986
Comparability of Hemodynamic Parameters Measured by Non-invasive Echocardiography and by Right Heart Catheterization
NCT03231774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sixty subjects (30 normotensive and30 hypertensives) will be included and studied once. Measurement will be performed in random order 3 time on the common carotid artery on both sides. Aortic stiffness will be measured by pulse wave velocity
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypertension patients
Local common carotid artery pulse wave velocity is compared in patients with hypertension and healthy volunteers.
No interventions assigned to this group
Healthy Volunteers
Local common carotid artery pulse wave velocity is compared in hypertension patients and healthy volunteers
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* essential (WHO workup),
* untreated (\> 28 days of treatment interruption, \< 6 months of treatment) on insufficiently equilibrated (BP \> 140 and/or 90 mmHg)
Exclusion Criteria
25 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
French Cardiology Society
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stéphane Laurent, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Pharmacology Department - Hopital Européen Georges Pompidou - Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Européen Georges Pompidou / Service de Pharmacologie
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID - RCB 2012-A01255-38
Identifier Type: OTHER
Identifier Source: secondary_id
2012-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.